Rising inflation and geopolitical forces are helping oil prices rise to stratospheric levels.

Climate change and a growing global population are combining to put water scarcity issues front...

Following some negative dividend action during the coronavirus-induced oil bear market of 2020,...

Technology stocks are rarely inexpensive, and that sentiment also applies to the semiconductor...

As an alternative to the bond markets, income-minded investors are turning to dividend-paying...

The latest stock market volatility witnessed the tech sector get a fresh round of sell-offs...

After ranking as the best-performing sector in the S&P 500 last year, energy is up to its old...

More innovation in robotics and artificial intelligence could bloom out of healthy competition,...

If the ongoing pandemic has taught anything, it’s the need for healthcare innovation....

Namely, there are now some attractive discounts available among chip equities, and that could...

Some market observers are saying that consolidation in the cloud computing arena will heat up...

Equities with the “disruptive” and “innovative” labels are being pinched to start 2022 amid...

Aggressive exchange traded fund traders are betting on a swift rebound in technology stocks after...

The Nasdaq-100 Index (NDX) and the related exchange traded funds, including QQQ and QQQM, are...

The biotechnology industry is a bifurcated space. In one corner, you have nascent, small-cap...

Stocks are off to an ominous start in 2022 with unprofitable, high-growth, and technology names...

The Invesco ESG NASDAQ 100 ETF (QQMG B-) is just three months old, but amid surging adoption of...

Growth stocks, particularly shares of companies that are losing money, are slumping in the early...

The global financial crisis in 2008 caused many retirees to fall behind their savings goals. With...

At a time when cases of the Omicron variant of COVID-19 are surging and inflation is rising at a...

Technology stocks and the growth style have been hammered, with the Nasdaq Composite Index close...

Although biotechnology stocks have been lackluster for the past year, the industry is gaining...

Among exchange traded funds focusing on shareholder rewards, advisors and investors typically...

In a sign that many investors see this dip in equity markets as temporary, a highly leveraged ETF...

As is now widely documented, biotechnology stocks and exchange traded funds endured a rough 2021....